Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Abbott Laboratories 12.593, Becton Dickinson 4.983.
Abbott Laboratories vs Becton Dickinson: Revenue Comparison
Abbott Laboratories (ABT) and Becton Dickinson (BDX) are peers in Healthcare. Abbott Laboratories reported revenue of $12.6B as of Q2 2026, compared with $5.0B for Becton Dickinson. Abbott Laboratories leads on revenue.
Abbott Laboratories's gross margin is 58.0% versus 46.5% for Becton Dickinson. Abbott Laboratories's net margin is 7.4% versus 7.6% for Becton Dickinson.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Abbott Laboratories, Becton Dickinson.| Metric | Abbott Laboratories | Becton Dickinson |
|---|---|---|
| Market Cap | - | - |
| Revenue | $12.59B | $4.98B |
| Cost of Revenue | $5.29B | $2.67B |
| Gross Profit | $7.30B | $2.31B |
| Operating Income | $1.78B | $663.00M |
| Net Income | $928.00M | $377.00M |
| R&D Expense | $882.00M | $258.00M |
| Earnings Per Share | $0.53 | $1.37 |
| Gross Margin | 58.0% | 46.5% |
| Operating Margin | 14.2% | 13.3% |
| Net Profit Margin | 7.4% | 7.6% |
| Free Cash Flow | $2.89B | $509.00M |
| Cumulative Free Cash Flow | $142.48B | $39.60B |
| Operating Cash Flow | $2.49B | $652.00M |
| Cash & Equivalents | $5.10B | $708.00M |